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Abstract
Background: Thrombin generation assay was developed several years ago to mimic physiological coagulation mechanisms but
it had important limitations. Thrombogram-Thrombinoscope assay using a fluorogenic substrate, allows obtaining thrombin
generation curves in non-defibrinated platelet rich plasma (PRP) in a fully automated manner.
Methods: We standardised the methodology of Thrombogram-Thrombinoscope and we evaluated the precision of thrombin
generation parameters (lag-time, maximum concentration of thrombin [Cmax], time required to reach Cmax [Tmax] and
endogenous thrombin potential ETP) using different concentrations of recombinant human tissue factor, platelets or
phospholipids. Normal values of thrombin generation assay were established in optimal experimental conditions.
Results:  In the presence of low TF concentrations (final dilution of thromboplastin in plasma: 1/1000–1/2000) the
Thrombogram assay showed intra-assay and inter-assay coefficients of variation lower than 9%. Thrombin generation
parameters showed an important inter-individual variability and the coefficients of variation ranged from 18% to 50%. In PRP the
lag-time, Cmax and Tmax but not the ETP, were influenced by TF concentration. Thrombin generation parameters were not
influenced by variations of platelet concentration from 50 × 109/l to 400 × 109/l. The addition of synthetic procoagulant
phospholipids in PPP strongly influenced all the parameters of thrombogram. For all the parameters of thrombogram a threshold
effect was observed in the presence of phspholipid concentrations equal or higher to 4 µM. In frozen-thawed PRP the lag-time
and the Tmax were significantly reduced and the Cmax was increased compared to the fresh PRP, but the ETP, the intra assay
and the inter-assay coefficients of variation were similar in both test-systems.
Conclusion: Thrombogram-Thrombinoscope assay performed in fresh or in frozen-thawed PRP has an acceptable precision,
with low inter-assay and intra-assay coefficient of variations. The concentration of TF is determinant for the normal values of
the studied parameters of thrombin generation. When the assay is performed in PPP, thrombin generation parameters are
influenced by the concentration of procoagulant synthetic phospholipids. The optimal experimental conditions were obtained
in the presence of 1/1000 final dilution of thromboplastin, a platelet count higher than 50 × 109/l and a synthetic phospholipid
concentration higher than 4 µM.
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Background
The global clotting times (i.e. prothrombin time and par-
tial thromboplastin time) are routinely used for the eval-
uation of human coagulation but they ignore the
procedure of thrombin generation since at the time of clot
formation only 3% of prothrombin is activated [1,2]. This
is a constant observation either in normal plasma or in the
presence of antithrombotic agents (i.e. enoxaparin or fon-
daparinux) [3]. The global clotting times are mandatory
for the detection of clotting factor deficiencies and the
biological monitoring of treatment with coumarins and
unfractionated heparin but they have a very limited value
in the detection of hypercoagulable states [1,2]. Moreover,
they are not significantly influenced by the presence of
therapeutic concentrations of LMWHs or the indirect FXa
inhibitors such as fondaparinux [3]. Measuring of anti-Xa
activity in plasma from patients treated with LMWHs has
a limited predictive value for the clinical outcome [4] and
in some patients' populations (i.e elderly or obese
patients) the anti-Xa levels in plasma are poorly correlated
with the administered dose of LMWH [5,6].
The study of thrombin generation performed either with
clotting based assays or with chromogenic substrates is an
old and established tool in blood coagulation research [7-
12]. It describes all the phases of thrombin generation
process (initiation, amplification and inhibition of
thrombin generation as well as the integral amount of
generated thrombin). According to the experimental sys-
tem used, thrombin generation may be influenced by
most of the factors playing a role in blood coagulation.
However, thrombin generation assessment used to be a
laborious and time-consuming method. The most sophis-
ticated version of thrombin generation assay using a chro-
mogenic substrate developed by Hemker's group was less
time-demanding than the previous one, since it was fully
automated accompanied with a software for the calcula-
tion of the area under thrombin generation curve (endog-
enous thrombin potential) [13]. The most important
experimental limitation of this assay was that it could be
done only in defibrinated platelet poor plasma (PPP).
Thus at least two important components of blood coagu-
lation (i.e. platelets and fibrinogen/fibrin) were absent
[14].
The Thrombogram-Thrombinoscope assay is a step for-
ward to the study of the blood coagulation process
because, using a fluorogenic substrate, it allows obtaining
thrombin generation curves in non-defibrinated platelet
rich plasma (PRP) in a fully automated manner [15]. An
increasing body of evidence shows that Thrombogram-
Thrombinoscope assay may be a useful tool in the diagno-
sis of acquired or congenital hypercoagulable states and it
is sensitive enough, in patients with hemorrhagic diathe-
sis [16, reviewed in 17]. Thrombogram is also sensitive to
the presence of antiplatelet and antithrombotic agents
[3,18].
Until now, there is an important heterogeneity regarding
the pre-analytical conditions and the experimental sys-
tems for the assessment of thrombogram. In addition, the
endogenous thrombin potential is the sole parameter of
thrombogram that has been systematically validated [19-
21]. Other parameters of thrombin generation curve given
by Thrombogram-Thrombinoscope®, such as the lag-time
of thrombin generation onset, the maximum concentra-
tion of generated thrombin and the time required to reach
the maximum concentration of thrombin have not been
systematically validated.
Standardization of thrombin generation using the Throm-
bogram-Thrombinoscope® method is necessary towards
the wide clinical use of the assay. The aim of this study was
to determine the influence of preanalytical and experi-
mental conditions on the Thrombogram-Thrombino-
scope assay. We examined the intra-assay, the inter-assay
and the inter-individual coefficients of variations of
thrombin generation lag-time, the maximum concentra-
tion of thrombin (Cmax), the time required to achieve
maximum thrombin generation (Tmax) and the endog-
enous thrombin potential (ETP) in fresh PRP and in fro-
zen-thawed PRP after triggering tissue factor (TF) pathway
in plasma from healthy volunteers and we established the
normal values for each parameter of the thrombogram.
We also studied the influence of experimental condition
such as the TF, concentration, and the platelet counts or
phospholipids concentration on each parameter of
thrombin generation curve given by the thrombogram.
Methods
Reagents
Bovine serum albumin (BSA) and Tris-HCl were obtained
from Sigma laboratories (St. Louis U.S.A.). Relipidated
recombinant tissue factor (Hemoliance® RecombiPlasTin)
was from Instrumentation Laboratory (Milan, Italy). The
Hemoliance® RecombiPlasTin reagent was reconstituted
by addition of 5 ml of NaCl 0.9%, and subsequently
diluted in Hepes buffer; pH 7.35 (containing 20 mM
Hepes, 140 mM NaCl and 5 mg/ml BSA) for the experi-
ments with the Thrombogram-Thrombinoscope™ assay
(Synapse b.v., Maastricht, The Netherlands). Thrombin
calibrator was also obtained by Synapse b.v. (Maastricht,
The Netherlands). The fluorogenic substrate Z-Gly-Gly-
Arg-AMC was obtained from Bachem (Bubendorf, Swit-
zerland). Unfractionated heparin was from Leo Laborato-
ries, commercially available enoxaparin preparation was
from Sanofi-Aventis Laboratories (Paris, France) and fon-
daparinux was from Glaxo Smith Klein (Paris, France).
Synthetic phospholipids (DOPS/DOPE/DOPC reconsti-
tuted according to manufacturer's instructions in a ratioThrombosis Journal 2005, 3:16 http://www.thrombosisjournal.com/content/3/1/16
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1:1:1,25) were obtained from Avanti Polar LipidsInC
(Albaster, Alabama, USA).
Normal human plasma
Venous blood was obtained from 22 healthy volunteers
non taking any medication, who are working in our labo-
ratory. Blood was collected with atraumatic antecubital
veinipuncture, into siliconized vacutainer tubes (Becton
Dickinson, Meylan, France) containing buffered triso-
dium citrate (0.129 mol/l, nine parts of blood and one
part of citrate solution). Thrombogram-Thrombino-
scope™ assay was performed in platelet rich plasma (PRP)
prepared after centrifugation of citrated whole blood for
10 min at 150 g at room temperature. The supernatant
PRP was removed and the platelet count was adjusted to
150 × 109/l by dilution with autologous PPP obtained
after a further centrifugation of the remaining blood for
15 min at 2000 g. To study the influence of platelet con-
centration on thrombin generation parameters, the plate-
let concentrations in PRP, prepared from 4 healthy
volunteers, were adjusted to, 10 × 109/l, 50 × 109/l, 100 ×
109/l, 150 × 109/l, 400 × 109/l by dilution with autolo-
gous PPP. To study the influence of phospholipids con-
centration on thrombin generation assay, frozen-thawed
PPP from three normal volunteers was spiked with
increasing concentrations of synthetic procoagulant phos-
pholipids (0, 2, 4 and 8 µM).
Thrombogram-Thrombinoscope assay
In each well of a micro-plate, 80 µl of the studied plasma
were mixed with 20 µl of diluted relipidated recombinant
tissue factor (Hemoliance® RecombiPlasTin) from Instru-
mentation Laboratory (Milan, Italy). The RecombiPlasTin
reagent was reconstituted by addition of 5 ml of NaCl
0.9%, and subsequently diluted in Hepes buffer pH 7.35;
containing 20 mM Hepes, 140 mM NaCl and 5 mg/ml
bovine serum albumin. The concentration of TF is not
given by the manufacturer and for this reason TF is
expressed as final dilution of recombiplastin in the
plasma. The following final dilutions of recombiplastn
were studied: 1/200, 1/500, 1/1000, 1/2000 which corre-
spond to a range of calculated TF concentration from 3
pM to 30 pM in plasma (TF levels in RecombiPlasTin rea-
gent were measured using an ELISA assay from American
Diagnostics Inc; data not shown). No inter-lot variability
of recombiplastin preparations was observed (data not
shown). Thrombogram was also performed without any
addition of TF.
Table 2: Inter-individual variability of thrombogram parameters in fresh PRP. Influence of TF concentration (n = 17). CV: coefficient of 
variations.
Recombiplastin final 
dilution in plasma and 
approximate TF 
concentration
Lag-time (% CV) ETP (% CV) Cmax (% CV) Tmax (% CV)
0 (0 pM) 24% 31% 45% 25%
1/2000 (3 pM) 24% 25% 35% 24%
1/1000 (6 pM) 24% 25% 31% 24%
1/500 (12 pM) 22% 25% 27% 20%
1/200 (30 pM) 28% 25% 15% 17%
Table 1: Precision analysis of each parameter of thrombin generation curve given by Thrombogram-Thrombinoscope assessed in fresh 
PRP in the presence of increasing TF concentrations or with out any TF addition. CV: coefficient of variation.
Recombiplastin final 
dilution in plasma and 
approximate TF 
concentration
Lag-time Tmax Cmax ETP
intra-assay 
CV
inter-assay 
CV
intra-assay 
CV
inter-assay 
CV
intra-assay 
CV
inter-assay 
CV
intra-assay 
CV
inter-assay 
CV
0 (0 pM) 7% 14% 5% 12% 5% 7% 4% 6%
1/2000 (3 pM) 4% 4% 4% 6% 6% 9% 4% 11%
1/1000 (6 pM) 4% 4% 3% 5% 6% 8% 3% 10%
1/500 (12 pM) 5% 6% 4% 6% 6% 8% 4% 5%
1/200 (30 pM) 6% 9% 5% 9% 3% 5% 4% 8%Thrombosis Journal 2005, 3:16 http://www.thrombosisjournal.com/content/3/1/16
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Thrombin generation was triggered by adding a solution
containing CaCl2 (16.7 mM final concentration) and the
fluorogenic substrate (Z-Gly-Gly-Arg-AMC, 417 µM final
concentration). A plate reader fluorometer (Fluoroskan
Ascent, ThermoLabsystems, Helsinki, Finland) and the
appropriate software (Thrombogram-Thrombinoscope™
assay; Synapse b.v., Maastricht, The Netherlands) were
used. Generated thrombin was quantified using a
thrombin calibrator kindly offered by Synapse b.v. Plas-
mas spiked with thrombin calibrator were run in parallel
with each cycle of test samples. The following parameters
were analyzed using the appropriate software provided by
Synapse b.v.: a) the lag time of thrombin generation, b)
the time to reach the maximum concentration (Tmax) of
thrombin, c) the maximum concentration (Cmax) of
thrombin and d) the total amount of thrombin activity
assessed as the area under the curve (i.e. the endogenous
thrombin potential – ETP).
Precision analysis of Thrombogram-Thrombinoscope assay
The intra-assay variability of each studied parameter of
Thrombogram-Thrombinoscope was assessed by repeat-
ing the assay 6 times on the same assay plate for each stud-
ied dilution of recombiplastin and the inter-assay
variability was assessed by repeating the assay 3 times, one
after the other on different assay plates. Inter-individual
variation was assessed by comparing the results obtained
in 22 healthy subjects.
Effect of TF concentration of thrombin generation parameters in PRP from 17 individuals (values are means ± sd) Figure 1
Effect of TF concentration of thrombin generation parameters in PRP from 17 individuals (values are means ± sd). According to 
the dosage of TF in RecomBiplasTin reagent performed in our laboratory, thromboplastin 1/1000 final dilution in plasma corre-
spond to 6 pM final TF concentration.
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Statistical analysis
Paired and unpaired Student's t-test were used to compare
the mean values of TG parameters in frozen and not fro-
zen PRP. SPSS statistical software package was used for
statistical analysis. Values are depicted as means ± sd.
Results
Intra-assay variability of thrombogram
When TF was added in PRP, the thrombogram parameters
showed acceptable intra-assay variability being equal or
lower than 9%. The performance of the assay was inde-
pendent of TF concentration (Table 1).
Inter-assay variability of thrombogram
All thrombogram parameters showed low inter-assay var-
iability when thrombin generation was assessed in the
presence of TF in PRP. Decreasing TF concentration did
not significantly influence the inter-assay variability of the
thrombogram parameters. In contrast, when no TF was
added in the experimental system the inter-assay variabil-
ity of the lag-time and the Tmax was considerably high
(14% and 12% respectively). In contrast the inter-assay
variability of the Cmax and the ETP was not significantly
influenced by the absence of TF (Table 1).
The intra-assay and inter-assay coefficients of variation of
the studied parameters were lower than 5% when
thrombin generation was studied in PRP spiked with UFH
(0.1 IU/ml to 1 IU/ml), or enoxaparin (0.1 anti-Xa IU/ml
to 1 anti-Xa IU/ml) or fondaparinux (0,1 µg/ml to 1 µg/
ml) in the presence of low TF concentration (final dilu-
tion of recombiplastin 1/2000).
Inter-individual variability of thrombogram
Thrombogram parameters showed an important inter-
individual variability and the coefficients of variation
ranged from 18% to 45% being even more important
when no TF was added. Among the studied parameters,
the ETP and the Cmax showed the highest inter-individ-
ual variability mainly when no TF was added (Table 2).
Influence of TF concentration on thrombogram in fresh 
PPP and PRP
Thrombin generation was triggered in fresh PRP from
healthy individuals without any TF addition as well as in
the presence of increasing TF concentrations (Figure 1).
When thrombin generation was studied in PRP without
any addition of TF a significant amount of thrombin was
generated (Cmax = 108 ± 9 nM, ETP = 1094 ± 40 nM ×
min) with a lag-time of 14 ± 3.3 min and a Tmax of 19.5
± 4.8 min. At recombiplastin dilution 1/2000, which cor-
responds to an approximate final concentration of TF of 3
pM, a threshold effect on the duration of the lag-time and
the Tmax was observed. Increasing the concentration of TF
resulted in an increase of the Cmax of thrombin. In con-
trast, the ETP was not influenced by the presence of TF,
since the difference between the ETP values in the absence
of TF and in the presence of recombiplastin dilution 1/
Table 4: Influence of platelet concentration on the normal values of thrombin generation parameters assessed by Thrombogram-
Thrombinoscope in the presence of 1/2000 final dilution of recombiplastin corresponding to estimated TF concentration of 3 pM. (n = 
7; means ± sd, *p < 0,05 versus the respective value in the presence of platelet counts 10 × 109/l.
Platelet concentration (× 
109/l)
lag-time (min) Tmax (min) Cmax (nM) ETP (nM × min)
400 5 ± 0,5 11 ± 2,7 161 ± 38 1633 ± 81
150 5,5 ± 0,5 11 ± 0,2 98 ± 40 1316 ± 255*
100 5,8 ± 0,7* 13 ± 0,9 72 ± 38 1135 ± 300
50 8 ± 3,3 12 ± 0,2* 63 ± 14* 1095 ± 301
10 8 ± 3 19 ± 2 43 ± 16 894 ± 100
Table 3: Normal values and inter-individual variability of thrombogram parameters in the presence of 1/1000 dilution of TF 
concentration in fresh PRP and in frozen-thawed PRP, (n = 22; mean ± sd).
Parameters of thrombin 
generation
Fresh PRP Frozen-thawed PRP
Normal value Inter-individual cv Normal value Inter-individual cv
Lag-time (min) 3.6 ± 0.8 24% 2 20%
ETP (nM × min) 1321 ± 330 25% 1550 ± 33 30%
Cmax (nM) 164 ± 50 31% 357 ± 1,66 25%
Tmax (min) 7.4 ± 1.8 24% 4,4 ± 0,1 25%Thrombosis Journal 2005, 3:16 http://www.thrombosisjournal.com/content/3/1/16
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2000 (which corresponds to approximately 3 pM final
concentration of TF) was not statistically significant (1094
± 340 nMxmin versus 1316 ± 255 nMxmin respectively; p
> 0,05) (Figure 1). Table 3 depicts the normal values of
Thrombogram parameters when coagulation is triggered
in the presence of 1/1000 final dilution of recombiplastin
(which corresponds to approximately 6 pM final concen-
tration of TF).
Effect of platelet concentration on Thrombogram
The effect of platelet count on thrombin generation was
studied in the presence of the lowest studied concentra-
tion of TF (1/2000 dilution of recombiplastin in plasma),
which showed an acceptable precision of the assay.
The lag-time of thrombin generation was similar (8 ± 3
min) in the presence of platelet counts 10 × 109/l and 50
× 109/l. In the presence of platelet count 100 × 109/l the
lag-time was significantly shorter (5,8 ± 0,7 min) as com-
pared to that observed in the presence of 50 × 109/l (8 ± 3
min; p < 0,05). No difference of the lag-time was observed
in platelet counts ranging from 100 × 109/l to 400 × 109/l
(5.5 ± 0.5 min) (Table 4).
The Tmax in the presence of platelet count 10 × 109/l was
19 ± 2 min being significantly longer as compared to that
observed in the presence of platelet count 50 × 109/l (12
± 0.2 min; p < 0.05). In the presence of platelet counts
ranging from 50 × 109/l to 400 × 109/l the Tmax of
thrombin generation did not significantly change (Table
4).
The Cmax of thrombin was significantly decreased in the
presence of platelet count 10 × 109/l, as compared to that
observed in the presence of platelet count 50 × 109/l (43
± 16 nM and 63 ± 14 nM respectively; p < 0.05). In the
Thrombogram parameters in the presence of thromboplastin dilutions in fresh PRP (white bars) and frozen-thawed PRP (shad- owed bars) (values are means of 4 experiments) Figure 2
Thrombogram parameters in the presence of thromboplastin dilutions in fresh PRP (white bars) and frozen-thawed PRP (shad-
owed bars) (values are means of 4 experiments).
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presence of platelet concentrations ranging from 50 × 109/
l to 400 × 109/l a slight but not statistically significant
increase of Cmax was observed (Table 4).
In the presence of platelet count 10 × 109/l the ETP was
significantly lower as compared to that observed in the
presence of platelet count 50 × 109/l (894 ± 100 and 1095
± 301 respectively; p < 0,05). In the presence of platelet
counts ranging from 150 × 109/l to 400 × 109/l no signif-
icant differences of the ETP were observed (Table 4).
Comparison of fresh and frozen-thawed platelet rich 
plasma for the assessment thrombogram
In thrombogram assessed in frozen-thawed PRP and in
fresh PRP without any exogenous addition of TF both the
lag-time and the Tmax were shorter by 45% and 51% and
the Cmax of thrombin increased by 200% in frozen PPR
as compared to the non frozen one (p < 0.05). The ETP
was less affected by the freezing, since in frozen-thawed
PRP it increased by only 6% as compared to that meas-
ured in fresh PRP (p > 0.05) (Figure 2).
In thrombogram assessed in the presence of TF, the ETP
was the sole parameter, which was not significantly
affected by the freezing (Figure 2). In frozen-thawed PRP,
in the presence of each studied concentration of TF the
lag-time decreased by 33% to 38% as compared to the
non frozen one (p < 0.05). The Tmax was more markedly
influenced by the freezing procedure mainly when mini-
mal amounts of TF were employed. It was reduced by 47%
in 1/1000 final dilution of recombiplastin in plasma,
38% in 1/500 final dilution of recombiplastin and 30% in
1/200 final dilution of recombiplastin as compared to the
respective values in fresh PRP (p < 0.05). The freezing also
affected the Cmax of thrombin, being significantly higher
in frozen-thawed than in fresh PRP. The increase of the
Cmax in frozen PRP was 119% in 1/1000 final dilution of
recombiplastin, 81% in 1/500 final dilution of recombi-
plastin and39% in the presence of 1/200 final dilution of
recombiplastin; in each case the difference was significant
(p < 0.001) as compared to the respective values in fresh
PRP.
The freezing procedure did not significantly influence the
inter-individual variability of thrombogram assay when
TF was added. In contrast freezing resulted in an impor-
tant diminution of the intra-assay coefficient of variations
of the ETP and Cmax when thrombogram was performed
without addition of TF (Table 5).
The normal values and the inter-individual coefficient of
variations of the studied parameters of thrombin genera-
tion after addition of 1/1000 final dilution of recombi-
plastin (approximately 6 pM TF) in fresh and in frozen-
thawed PRP are summarized in Table 3.
The influence of synthetic phospholipid concentration on 
thrombin generation in PPP
The addition of synthetic procoagulant phospholipids in
PPP strongly influenced all the parameters of thrombo-
gram (Figure 3). Both the lag-time and the Tmax of
thrombin generation were strongly dependent on the
presence of procoagulant phospholipids when no TF was
added. In the presence of 3 pM of TF both parameters were
influenced to a less significant degree by the concentra-
tion of phospholipids. In contrast the impact of the pro-
coagulant phospholipids was important on both the ETP
and the Cmax of thrombin either in the absence of TF or
in the presence of low (3 pM) or higher concentrations
(30 pM). For all the parameters of thrombogram a thresh-
old effect was observed in the presence of phsopholipid
concentrations equal or higher to 4 µM. However, since
the Cmax appeared a slight, though not significant
increase in the presence of synthetic phospholipid con-
centration of 8 µM, the optimum concentration of phos-
pholipids is situated at 8 µM.
Discussion
In the present study thrombin generation was assessed
with the automated Thrombogram-Thrombinoscope
assay. The precision of thrombogram, was evaluated in
the presence of increasing TF concentrations, of synthetic
procoagulant phospholipids, platelet count and freezing
– thawing of platelet rich plasma from healthy volunteers.
Normal values of thrombin generation in defined experi-
mental, conditions which can be applied in routine hae-
mostasis laboratory have also been established.
Table 5: Intra-assay coefficients of variation of the studied parameters of thrombogram in fresh and frozen-thawed PRP (n = 4).
Lag-time ETP Cmax Tmax
TF dilution Fresh PRP Frozen-
thawed PRP
Fresh PRP Frozen-
thawed PRP
Fresh PRP Frozen-
thawed PRP
Fresh PRP Frozen-
thawed PRP
TF 1/200 0 % 0% 3,5% 2,6% 1% 0,7% 3,5% 0%
TF 1/500 0% 0% 3% 1,6% 1,6% 1,1% 4,1% 4%
TF 1/1000 0% 0% 2,1% 2,1% 5,2% 0,5% 2,9% 2,8%
without TF 3,6% 8,1% 4,2% 2,7% 9,8% 1,7% 4,3% 5,1%Thrombosis Journal 2005, 3:16 http://www.thrombosisjournal.com/content/3/1/16
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In the presence of a standardized platelet concentration
(150 × 109/l) without any addition of TF all the studied
parameters of thrombin generation can be measured.
Thus we confirm that the presence of procoagulant phos-
pholipids derived from platelets as in our study, is of
major importance for steady thrombin generation [22].
The presence of platelets as is the case in our study, or the
in vitro addition of negatively charged phospholipids in
PPP [20] creates a more physiologically relevant experi-
mental system.
The amplification of thrombin generation also depends
on the concentration of the initial stimulus. According to
the old scheme of blood coagulation (the cascade
scheme) [23,24] one can trigger either the TF pathway or
the contact system (intrinsic pathway) in order to study
thrombin generation. However, the classic cascade
scheme has a limited physiological relevance. It is now
generally accepted that tiny amounts of TF, either blood
born (from microparticles or activated monocytes) or
exposed at the site of vascular injury, bind to FVII and
FVIIa and the complex TF/FVIIa triggers blood coagula-
tion [25]. Therefore we validated the Thrombogram-
Thrombinoscope assay in TF-induced coagulation of nor-
mal plasma. As it was expected, in PRP the lag-time of
thrombin generation onset, the Cmax of thrombin and
the Tmax were strongly influenced by the TF concentra-
tion. The values of the lag-time, Cmax, Tmax and ETP in
PRP did not significantly vary when physiologically rele-
vant concentrations of TF, ranging from 1/2000 to 1/1000
dilution of recombiplastin, were used (which correspond
to approximately 3 pM to 6 pM of TF).
Thrombogram assay performed in the presence of TF con-
centrations (3 pM to6 pM) which are considered to be
physiologically relevant, had a low inter-assay and intra-
Influence of increasing concentrations of synthetic procoagulant phospholipids added in normal PPP Figure 3
Influence of increasing concentrations of synthetic procoagulant phospholipids added in normal PPP. Thrombin generation was 
triggered in the presence of thromboplastin diluted in plasma 1/200 (30 pM TF) or 1/2000 (3 pM TF) or without any addition of 
TF. Values are means of 3 experiments.
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assay coefficients of variation in PRP revealing that the
precision of the assay is marginally influenced by the con-
centration of TF. However, all the studied parameters of
thrombogram performed in PRP showed an important
inter-individual variability, which was not improved by
the addition of TF. Chantarangkul et al [20] showed that
the presence of residual platelets into the PPP influences
the imprecision of the ETP measurement. Our study
shows that the inter-individual variability is important in
fresh PRP, as well as in frozen-thawed PRP and is not
influenced when the platelet count ranges from 10 × 109/
l to 400 × 109/l (data not shown). A significant individual
dependent variation in thrombogram has also been
reported by Vanschoonbeek et al [26]. Thus it seems that
individual functional characteristics of platelets, which
are not completely understood today, as well as variations
of the concentration of clotting factors and the natural
inhibitors of blood coagulation [27] influence thrombin
generation profile and they can be detected by the throm-
bogram assay. Platelet debris or microparticles present in
PPP might have a major contribution to the observed sig-
nificant interindividual variability of thrombin genera-
tion assay either in the absence or in the presence of TF
since they exert a "non standardized" procoagulant activ-
ity. In order to eliminate this unpredictable factor it has
been proposed that complete platelet depletion (i.e. by fil-
tration of PPP) or addition of an excess concentration of
phospholipids in PPP may improve the inter-individual
variability of thrombogram [20]. We have to stress out
that in the presence of very low TF concentration (3 pM)
or in its absence, the CV values of the interindividual var-
iability of thrombin's Cmax are considerably high. This
finding allows to postulate that in conditions where the
initial trigger of coagulation process is weak the experi-
mental system is quite unstable. In such conditions the
impact of artifacts such as platelet debris or probably the
presence of procoagulant material such as microparticles
is more important. It has been widely recognized that the
major contribution of the Thrombogram-Thrombino-
scope methodology is that it allows the study of thrombin
generation in a more physiologically relevant system
where platelets and fibrinogen/fibrin are present.
Whether it is better to omit platelets from the experimen-
tal system has to be controlled in more detailed studies in
larger groups of normal individuals and of patients with
hyper- or hypo-coagulant states. In any case the large
inter-individual variation could make more difficult the
interpretation of the results.
Another important aspect of Thrombogram-Thrombino-
scope assay is that the studied parameters are not signifi-
cantly influenced by quantitative platelet variations
within a quite wide range of platelet concentration (from
50 × 109/l to 400 × 109/l). As we have described in details
elsewhere [28] and in accordance with the findings from
Chantarangkul et al [20] thrombin generation is signifi-
cantly reduced when platelet count is lower than 50 × 109/
l. Consequently, deviations from the normal platelet con-
centrations do not significantly influence neither the pre-
cision of the assay nor the reference normal values.
Freezing procedure of PRP significantly reduced the lag-
time and the Tmax and also increased the Cmax of gener-
ated thrombin but it did not significantly affect the ETP.
Thus in frozen-thawed PRP thrombin generation is accel-
erated and the maximum amount of generated thrombin
is increased apparently due to cold-induced platelet acti-
vation and/or procoagulant phospholipids release. How-
ever, the integral amount of thrombin generated in time,
expressed by the ETP is not modified. In addition, freezing
does not modify the coefficients of variation of all the
studied parameters of thrombogram when thrombin gen-
eration was triggered in the presence of TF showing once
more that the high interindividual variability of the assay
is poorly related to technical conditions. Consequently
ETP is the single parameter of Thrombogram which can be
assessed in frozen-thawed PRP but weather its sensitivity
to detect pathological hypercoagulable or hypocoagulable
conditions needs to be examined. From a practical point
of view, when clotting is triggered in PPP spiked with syn-
thetic procoagulant phospholipids at concentrations
higher than 4 µM in the presence of low TF concentration
(1/2000 recombiplastin dilution in plasma) results in a
similar pattern of thrombogram as that observed when
PRP was used. In addition the ensemble of the presented
data show that the ETP is influenced more by the concen-
tration of procoagulant phospholipids rather than by the
concentration of TF.
In conclusion, the present study shows that Thrombo-
gram-Thrombinoscope assay performed in fresh platelet
rich plasma has an acceptable precision, with low inter-
assay and intra-assay coefficient of variations. The concen-
tration of TF is determinant for the normal values of all
the studied parameters except the endogenous thrombin
potential. The addition of physiologically relevant con-
centrations of TF in platelet rich plasma (1/1000 to 1/
2000 final dilution of recombiplastin) simulates a more
natural experimental system from which however, the
white and red blood cell as well as the rheological condi-
tions are absent. Assessing thrombin generation in frozen-
thawed PRP induces an important bias on the normal val-
ues of all the parameters of thrombogram except the ETP.
In contrast, the thrombogram parameters obtained in fro-
zen-thawed PPP supplemented with synthetic procoagu-
lant phospholipids at concentrations equal or superior
than 4 µM and physiologically relevant concentrations of
TF is quite similar to that obtained in PRP in the presence
of the same TF concentration. Regarding all the parame-
ters of thrombin generation, the optimal concentration ofThrombosis Journal 2005, 3:16 http://www.thrombosisjournal.com/content/3/1/16
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the synthetic phospholipids employed in the present
study is situated at 8 µM. The use of a standardized
thrombin calibrator, which runs in parallel with the stud-
ied samples, allows the quantitative expression of
thrombin in nM and ETP in nM × min. In addition,
thrombogram software can reliably describe the distinct
phases of thrombin generation (i.e the initiation phase,
the Tmax and the maximum concentration of the gener-
ated thrombin). Among the studied parameters of
thrombin generation given by the Thrombogram-
Thrombinoscope assay, the ETP is less influenced by the
concentration of TF as well as by the pre-analytical condi-
tions (fresh PRP or frozen-thawed PRP) but it is strongly
influenced by the concentration of phospholipids when it
is performed in PPP. The influence of commercially avail-
able citrate preparations on thrombogram has to be eval-
uated in future studies. Thrombogram-Thrombinoscope
assay is sensitive to the presence of UFH, enoxaparin and
fondaparinux with low intra-assay and inter-assay varia-
bility. However, we have shown that the lag-time and the
velocity of the propagation phase are more relevant than
the ETP when an indirect FXa inhibitor (fondaparinux) or
rFVIIa are present in therapeutic concentrations [3,28].
The method can be useful for the study of different anti-
thrombotic agents whatever their mechanism of action
and their target (LMWHs, direct and indirect inhibitors of
FXa and direct inhibitors of thrombin [3,17,29,30]. Thus
the ensemble of the parameters of thrombin generation
can be potentially used for the laboratory diagnosis and
biological of a large spectrum of hyper- and hypo-coagu-
lant states. The high inter-individual variability of throm-
bogram is a topic that has to be studied in details in a large
collaborative study.
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